344 related articles for article (PubMed ID: 30481269)
41. Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016.
McLean HQ; King JP; Talley P; Flannery B; Spencer S; Levine MZ; Friedrich TC; Belongia EA
J Pediatric Infect Dis Soc; 2020 Apr; 9(2):173-180. PubMed ID: 30759228
[TBL] [Abstract][Full Text] [Related]
42. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine.
Ambrose CS; Wu X; Jones T; Mallory RM
Vaccine; 2012 Nov; 30(48):6794-801. PubMed ID: 23000125
[TBL] [Abstract][Full Text] [Related]
43. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
[TBL] [Abstract][Full Text] [Related]
44. HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy.
Gilbert PB; Fong Y; Juraska M; Carpp LN; Monto AS; Martin ET; Petrie JG
BMC Infect Dis; 2019 May; 19(1):453. PubMed ID: 31117986
[TBL] [Abstract][Full Text] [Related]
45. Live-Attenuated Influenza Vaccine Induces Tonsillar Follicular T Helper Cell Responses That Correlate With Antibody Induction.
Lartey S; Zhou F; Brokstad KA; Mohn KG; Slettevoll SA; Pathirana RD; Cox RJ
J Infect Dis; 2020 Jan; 221(1):21-32. PubMed ID: 31250024
[TBL] [Abstract][Full Text] [Related]
46. B- and T-cell memory elicited by a seasonal live attenuated reassortant influenza vaccine: assessment of local antibody avidity and virus-specific memory T-cells using trogocytosis-based method.
Petukhova G; Korenkov D; Chirkova T; Donina S; Rudenko L; Naykhin A
Influenza Other Respir Viruses; 2012 Mar; 6(2):119-26. PubMed ID: 21819548
[TBL] [Abstract][Full Text] [Related]
47. Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
Ghorbani A; Ngunjiri JM; Xia M; Elaish M; Jang H; Mahesh KC; Abundo MC; Jiang X; Lee CW
Vaccine; 2019 Feb; 37(10):1356-1364. PubMed ID: 30691981
[TBL] [Abstract][Full Text] [Related]
48. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
[TBL] [Abstract][Full Text] [Related]
49. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
Isakova-Sivak I; Rudenko L
Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
[TBL] [Abstract][Full Text] [Related]
50. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.
Levin MJ; Song LY; Fenton T; Nachman S; Patterson J; Walker R; Kemble G; Allende M; Hultquist M; Yi T; Nowak B; Weinberg A
Vaccine; 2008 Aug; 26(33):4210-7. PubMed ID: 18597900
[TBL] [Abstract][Full Text] [Related]
51. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.
Hoft DF; Babusis E; Worku S; Spencer CT; Lottenbach K; Truscott SM; Abate G; Sakala IG; Edwards KM; Creech CB; Gerber MA; Bernstein DI; Newman F; Graham I; Anderson EL; Belshe RB
J Infect Dis; 2011 Sep; 204(6):845-53. PubMed ID: 21846636
[TBL] [Abstract][Full Text] [Related]
52. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
[TBL] [Abstract][Full Text] [Related]
53. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
Talaat KR; Karron RA; Liang PH; McMahon BA; Luke CJ; Thumar B; Chen GL; Min JY; Lamirande EW; Jin H; Coelingh KL; Kemble GW; Subbarao K
Influenza Other Respir Viruses; 2013 Jan; 7(1):66-73. PubMed ID: 22417012
[TBL] [Abstract][Full Text] [Related]
54. Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children.
Weinberg A; Song LY; Walker R; Allende M; Fenton T; Patterson-Bartlett J; Nachman S; Kemble G; Yi TT; Defechereux P; Wara D; Read JS; Levin M;
J Acquir Immune Defic Syndr; 2010 Oct; 55(2):189-96. PubMed ID: 20581690
[TBL] [Abstract][Full Text] [Related]
55. Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.
Babu TM; Levine M; Fitzgerald T; Luke C; Sangster MY; Jin H; Topham D; Katz J; Treanor J; Subbarao K
Vaccine; 2014 Nov; 32(50):6798-804. PubMed ID: 25446831
[TBL] [Abstract][Full Text] [Related]
56. Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.
Cao RG; Suarez NM; Obermoser G; Lopez SM; Flano E; Mertz SE; Albrecht RA; García-Sastre A; Mejias A; Xu H; Qin H; Blankenship D; Palucka K; Pascual V; Ramilo O
J Infect Dis; 2014 Jul; 210(2):224-33. PubMed ID: 24495909
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial.
Brooks WA; Zaman K; Lewis KD; Ortiz JR; Goswami D; Feser J; Sharmeen AT; Nahar K; Rahman M; Rahman MZ; Barin B; Yunus M; Fry AM; Bresee J; Azim T; Neuzil KM
Lancet Glob Health; 2016 Dec; 4(12):e946-e954. PubMed ID: 27746226
[TBL] [Abstract][Full Text] [Related]
59. Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
Korenkov DA; Laurie KL; Reading PC; Carolan LA; Chan KF; Isakova-Sivak II; Smolonogina TA; Subbarao K; Barr IG; Villanueva J; Shcherbik S; Bousse T; Rudenko LG
Infect Genet Evol; 2018 Oct; 64():95-104. PubMed ID: 29929009
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets.
Shen Z; Bowen RA; Ge P; Yu J; Shen Y; Kong W; Jiang C; Wu J; Zhu C; Xu Y; Wei W; Rudenko L; Kiseleva I; Xu F
Vaccine; 2016 Nov; 34(48):5953-5958. PubMed ID: 27997342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
